Lung Cancer Europe’s Post

🫁 Today is World Lung Cancer Day, a day dedicated to raising awareness about this prevalent form of cancer.   The diagnosis can be frightening, but research and new treatments offer hope. The Com.pl.i.t DX® Lung test is a significant step towards conquering lung cancer.   How does the ComPlit DX® Lung test assist the doctor and the patient in treatment?   The test provides crucial information about the tumor's biology and can lead to the identification of mutations that cause carcinogenesis, known as "Driver Mutations." This information helps physicians and patients arrive at the most effective personalized treatment for Non-Small Cell Lung Cancer (NSCLC).   Learn more about the test: https://lnkd.in/gFzieaXn   #WorldLungCancerDay #LungCancer #LungCancerAwareness #Genekor

🔬 #Immunotherapy #CancerResearch | This article by Cancer Research UK (CRUK) explores how tracking the co-evolution of tumors and the immune system can enhance cancer treatments. Understanding the dynamic interaction between cancer cells and the immune system is crucial for developing more effective therapies. This article highlights the importance of studying these interactions over time and space to target cancer cells at their most vulnerable 🔽

Scientists used cancer to annihilate cancer. The disease got a taste of its own medicine when researchers harnessed immune cells armed with mutations found in cancer to destroy tumors in mice, according to a new study. Although engineering patients’ T cells (a type of white blood cell) to attack blood cancers has been a cornerstone of immunotherapy for years, the technique has been less effective for treating other types of cancer. The new research altered T cells with genetic mutations present in cancerous ones and found they could infiltrate and “melt” various tumors. A biotech startup aims to start testing it in humans in 2-to-3 year https://lnkd.in/eNJ2GvX2

September is Prostate Cancer Awareness Month. Prostate cancer is the most common type of cancer diagnosed in men in the United States, and the second leading cause of cancer deaths in men, after lung cancer. -The American Association for Cancer Research (AACR) African American men specifically are at higher risk of getting and dying from prostate cancer than any other group. So it's important for us to understand the risk factors factors associated with prostate cancer, and emphasize the importance of consistent prostate cancer tests to catch the cancer early. #ProstateCancerAwarenessMonth #ProstateCancer #cancer #cancerresearch #cancertreatment

Targeted therapy plays an important role for patients with early and advanced-stage non-small cell lung cancer carrying specific genetic alterations. In this video, Dr. Maisam Makarem and Dr. Pasi Jänne of Dana-Farber Cancer Institute break down the latest advances in targeted therapy for lung cancer. Learn more about the latest advances in targeted therapy for lung cancer: https://lnkd.in/eH9wd_aN OncoAlert American Cancer Society #lungcancer #lungcancerresearch #targetedtherapy

With August 1st being #WorldLungCancerDay, the latest advances for lung cancer are top of mind. Check out the video below sharing more on targeted therapy and how it is helping patients.

New research sheds light on an unexpected potential ally against cancer: parasites. Studies show they might boost immune responses, block tumour growth, and mimic cancer cells, opening up new cancer treatment possibilities, including for lung cancer. This emerging field could reshape our approach to cancer therapy. Find out more 🔗 https://lnkd.in/etRY6paU #LungCancerResearch #LungCancer #ALKPositive

Cancer metastasis is the spread of cancer cells from the primary tumor to other parts of the body. This involves several steps: cancer cells invade nearby tissues, enter the bloodstream or lymphatic system, travel to distant sites, exit the vessels, and establish new tumors. Metastasis is a major cause of cancer mortality and complicates treatment, making it crucial to understand and target in cancer research.

🔬 Breakthrough in Cancer Research 🔬 UC Irvine's team led by Remi Buisson has identified two key enzymes, APOBEC3A and APOBEC3B, as new targets for cancer treatment strategies. This landmark discovery highlights their role in cancer mutation, disease progression, and resistance to treatments. Dr. Buisson’s work was initially funded by the UCI Anti-Cancer Challenge in 2018. Support from the UCI Anti-Cancer Challenge propels essential research efforts like these, moving us closer to defeating cancer. Read more about how this research could transform cancer therapy at https://lnkd.in/gbkRC3aU. #cancerresearch #cancertreatment #supportcancerresearch

🐭Excited to present Biocytogen 's advancements in cancer vaccine development using Biocytogen humanized HLA mouse models at the Cancer Research Institute's 8th International Cancer Immunotherapy Conference (#CICON24) in Washington, DC. Looking forward to sharing insights on how we’re leveraging these models to push the boundaries of immunotherapy research! #CancerResearch #Immunotherapy #HumanizedMice #CICON24